6:34 PM
 | 
Mar 23, 2009
 |  BC Extra  |  Company News

SkyePharma submits Flutiform NDA

SkyePharma (LSE:SKP) submitted an NDA to FDA for Flutiform fluticasone/formoterol for maintenance...

Read the full 49 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >